Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell line
E. Rabizadeh, V. Merkin, I. Belyaeva, M. Shaklai, Y. Zimra
Research output: Contribution to journal › Article › peer-review
14Scopus
citations
Fingerprint
Dive into the research topics of 'Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell line'. Together they form a unique fingerprint.